Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wilms Tumor 1Recurrence 1Death 1Colorectal Neoplasms 1

Interventions

Filgrastim 10Cyclophosphamide 8Granulocyte Colony-Stimulating Factor 6Melphalan 5Busulfan 5Vincristine 4Topotecan 4Temozolomide 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Ifosfamide 4Etoposide 4Thiotepa 3Radiotherapy 3Mesna 3Itraconazole 3Doxorubicin 3Cisplatin 3Carboplatin 3sargramostim 2fludarabine 2Therapeutics 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Drug Therapy 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Wilms Tumor × Genes, p53 × Clear all
NCT04758455 2021-02-17

The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence

Mansoura University

Phase NA Unknown
75 enrolled
Genitourinary

Death, Wilms Tumor, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡